BBOT
BridgeBio Oncology Therapeutics, Inc.
NASDAQ: BBOT · HEALTHCARE · BIOTECHNOLOGY
$8.41
+4.34% today
Updated 2026-04-30
Market cap
$702.69M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.30
Dividend yield
—
52W range
$8 – $15
Volume
0.3M
BridgeBio Oncology Therapeutics, Inc. (BBOT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | — | — | $-52.08M | $-763820.00 | $-113.89M |
| Capital expenditures | $0.00 | $0.00 | $414000.00 | $49000.00 | $606000.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | — | — | $16.46M | $271572.00 | $5.87M |
| Free cash flow | — | — | $-52.49M | $-812820.00 | $-114.50M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |